
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
A precision medicine approach to metabolic therapy for breast cancer in mice
Ngozi D. Akingbesote, Aaron D. Norman, Wanling Zhu, et al.
Communications Biology (2022) Vol. 5, Iss. 1
Open Access | Times Cited: 13
Ngozi D. Akingbesote, Aaron D. Norman, Wanling Zhu, et al.
Communications Biology (2022) Vol. 5, Iss. 1
Open Access | Times Cited: 13
Showing 13 citing articles:
Investigation of co-treatment multi-targeting approaches in breast cancer cell lines
Jéssica Brzoskowski Longaray, Camila Kehl Dias, Juliete Nathali Scholl, et al.
European Journal of Pharmacology (2024) Vol. 966, pp. 176328-176328
Closed Access | Times Cited: 4
Jéssica Brzoskowski Longaray, Camila Kehl Dias, Juliete Nathali Scholl, et al.
European Journal of Pharmacology (2024) Vol. 966, pp. 176328-176328
Closed Access | Times Cited: 4
Exploring the anti-cancer potential of SGLT2 inhibitors in breast cancer treatment in pre-clinical and clinical studies
Yasaman Naeimzadeh, Amir Tajbakhsh, Mahnaz Nemati, et al.
European Journal of Pharmacology (2024) Vol. 978, pp. 176803-176803
Closed Access | Times Cited: 3
Yasaman Naeimzadeh, Amir Tajbakhsh, Mahnaz Nemati, et al.
European Journal of Pharmacology (2024) Vol. 978, pp. 176803-176803
Closed Access | Times Cited: 3
Dichloroacetate as a novel pharmaceutical treatment for cancer-related fatigue in melanoma
Xinyi Zhang, Won D. Lee, Brooks P. Leitner, et al.
AJP Endocrinology and Metabolism (2023) Vol. 325, Iss. 4, pp. E363-E375
Closed Access | Times Cited: 7
Xinyi Zhang, Won D. Lee, Brooks P. Leitner, et al.
AJP Endocrinology and Metabolism (2023) Vol. 325, Iss. 4, pp. E363-E375
Closed Access | Times Cited: 7
Optimal control strategies for SGLT2 inhibitors as a novel anti-tumor agent and their effect on human breast cancer cells with the effect of time delay and hyperglycemia
Abeer Hamdan Alblowy, Normah Maan, Abdulkareem Afolabi Ibrahim
Computers in Biology and Medicine (2023) Vol. 166, pp. 107552-107552
Open Access | Times Cited: 7
Abeer Hamdan Alblowy, Normah Maan, Abdulkareem Afolabi Ibrahim
Computers in Biology and Medicine (2023) Vol. 166, pp. 107552-107552
Open Access | Times Cited: 7
Thiazolidinedione enhances the efficacy of anti-PD-1 monoclonal antibody in murine melanoma
Xinyi Zhang, Yuan Gao, Keyun Tang, et al.
AJP Endocrinology and Metabolism (2024) Vol. 326, Iss. 3, pp. E341-E350
Closed Access | Times Cited: 1
Xinyi Zhang, Yuan Gao, Keyun Tang, et al.
AJP Endocrinology and Metabolism (2024) Vol. 326, Iss. 3, pp. E341-E350
Closed Access | Times Cited: 1
Obesity-Associated Colorectal Cancer
Lucía G. Gutiérrez, Omar Motiño, Daniel Barriuso, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 16, pp. 8836-8836
Open Access | Times Cited: 1
Lucía G. Gutiérrez, Omar Motiño, Daniel Barriuso, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 16, pp. 8836-8836
Open Access | Times Cited: 1
Potential Therapies Targeting the Metabolic Reprogramming of Diabetes-Associated Breast Cancer
Hang Chee Erin Shum, Ke Wu, Jaydutt V. Vadgama, et al.
Journal of Personalized Medicine (2023) Vol. 13, Iss. 1, pp. 157-157
Open Access | Times Cited: 4
Hang Chee Erin Shum, Ke Wu, Jaydutt V. Vadgama, et al.
Journal of Personalized Medicine (2023) Vol. 13, Iss. 1, pp. 157-157
Open Access | Times Cited: 4
Immunometabolism at the crossroads of obesity and cancer—a Keystone Symposia report
Jennifer Cable, Jeffrey C. Rathmell, Erika L. Pearce, et al.
Annals of the New York Academy of Sciences (2023) Vol. 1523, Iss. 1, pp. 38-50
Closed Access | Times Cited: 3
Jennifer Cable, Jeffrey C. Rathmell, Erika L. Pearce, et al.
Annals of the New York Academy of Sciences (2023) Vol. 1523, Iss. 1, pp. 38-50
Closed Access | Times Cited: 3
Metabolic underpinnings of cancer-related fatigue
Xinyi Zhang, Rachel J. Perry
AJP Endocrinology and Metabolism (2024) Vol. 326, Iss. 3, pp. E290-E307
Closed Access
Xinyi Zhang, Rachel J. Perry
AJP Endocrinology and Metabolism (2024) Vol. 326, Iss. 3, pp. E290-E307
Closed Access
Predictive model for pancreatic steatosis after neoadjuvant chemotherapy in breast cancer: Construction and ultrasound validation
Helin Ke, Jiaojiao Lin, Lina Han, et al.
Journal of Radiation Research and Applied Sciences (2024) Vol. 17, Iss. 2, pp. 100888-100888
Open Access
Helin Ke, Jiaojiao Lin, Lina Han, et al.
Journal of Radiation Research and Applied Sciences (2024) Vol. 17, Iss. 2, pp. 100888-100888
Open Access
Understanding the Role of Adipocytes and Fibroblasts in Cancer
Mauricio A. Downer, Michelle Griffin, Annah Morgan, et al.
Annals of Plastic Surgery (2023) Vol. 91, Iss. 6, pp. 779-783
Open Access | Times Cited: 1
Mauricio A. Downer, Michelle Griffin, Annah Morgan, et al.
Annals of Plastic Surgery (2023) Vol. 91, Iss. 6, pp. 779-783
Open Access | Times Cited: 1
A review of the impact of energy balance on triple-negative breast cancer
Ngozi D. Akingbesote, Dennis Owusu, Ryan Liu, et al.
JNCI Monographs (2023) Vol. 2023, Iss. 61, pp. 104-124
Open Access
Ngozi D. Akingbesote, Dennis Owusu, Ryan Liu, et al.
JNCI Monographs (2023) Vol. 2023, Iss. 61, pp. 104-124
Open Access
Effectiveness of the alternative drugs and other factors in adjuvant treatment for the malignant tumors
В. А. Чубенко
Practical oncology (2023) Vol. 23, Iss. 4, pp. 383-394
Open Access
В. А. Чубенко
Practical oncology (2023) Vol. 23, Iss. 4, pp. 383-394
Open Access